Turkiye Klinikleri Journal of Health Sciences

.: REVIEW
Lösemili Çocuklarda Beslenmenin Kısa ve Uzun Dönem Etkileri: Geleneksel Derleme
Short and Long-Term Effects of Nutrition in Children with Leukemia: Traditional Review
Hakan TOĞUÇa, Hande ÖNGÜN YILMAZb
aTurgut Özal Üniversitesi Malatya Eğitim ve Araştırma Hastanesi, Beslenme ve Diyetetik Kliniği, Malatya, TÜRKİYE
bİstanbul Okan Üniversitesi Sağlık Bilimleri Fakültesi, Beslenme ve Diyetetik Bölümü, İstanbul, TÜRKİYE
Turkiye Klinikleri J Health Sci. 2021;6(4):958-64
doi: 10.5336/healthsci.2020-80719
Article Language: TR
Full Text
ÖZET
 Lösemi, çocukluk çağı kanserlerinin önemli bir kısmını oluşturan, uzun ve zorlu tedavi süreci gerektiren malign bir hastalık grubudur. Ülkemizde ve dünyada her yıl binlerce çocuk bu hastalıktan dolayı kaybedilmektedir. Lösemili çocuklarda anemi, ateş, splenomegali, hepatomegali gibi birçok klinik belirti bulunmaktadır. Hastaların tedavileri süresince sık sık enfeksiyöz, renal, gastrointestinal, endokrinolojik ve nörolojik sistemlere ait komplikasyonlar görülmektedir. Lösemili çocukların tedavi ve iyileşme dönemlerinde yeterli ve dengeli beslenme büyük bir öneme sahiptir. Hastalık tedavisinin ilk dönemlerinde komplikasyonlar, ilaç tedavileri ve hastalık psikolojisi nedeniyle yetersiz ve dengesiz beslenme görülmekte, bu durum malnütrisyon ve büyüme geriliği ile sonuçlanabilmektedir. Fakat tedavinin ileri dönemleri veya iyileşme dönemlerinde kullanılan ilaç tedavisi, besin tüketim özlemi, psikolojik hastalık yükü ve düzensiz yaşam tarzı kaynaklı obezite, sarkopenik obezite, kardiyovasküler hastalıklar ve beraberinde getirdiği yeni hastalık semptomları görülebilmektedir. Uzun süreli yaşanan düzensiz beslenme ile besin ögesi yetersizlikleri ve anemi gibi komplikasyonları ortaya çıkmaktadır. Bu dönemde çocukların beslenme düzenlerinde ebeveynlerin rolü de önem arz etmektedir. Ebeveynler çocukların tedavilerinin ilk dönemlerinde aşırı beslenme baskısı yaparken, iyileşme sonrasında durumu kontrol altına almakta zorlanmaktadırlar. Bu yüzden tedavi sonrası sağkalım görülen çocuklarda yaşıtlarına kıyasla kronik hastalıklara yakalanma riski yüksek görülmektedir. Bu durum hastalığın beslenme ile ilişkisinin önemli olduğu ve konunun uzmanı diyetisyenlere ihtiyaç olduğunu göstermektedir.

Anahtar Kelimeler: Lösemi; çocuk; malnütrisyon; obezite
ABSTRACT
 Leukemia is a malignant disease group that constitutes an important part of childhood cancer and requires a long and demanding treatment process. Every year thousands of children are died in our country and in the world due to this disease. Children with leukemia have many clinical symptoms such as anemia, fever, splenomegaly, and hepatomegaly. Complications of infectious, renal, gastrointestinal, endocrinological and neurological systems are frequently observed during the treatment of patients. Adequate and balanced nutrition is of great importance in the treatment and recovery periods of children with leukemia. In the early stages of disease treatment, inadequate and unbalanced nutrition is observed due to complications, drug treatments and disease psychology, which may result in malnutrition and growth retardation. However, drug therapy, nutrient consumption craving, psychological disease burden and irregular lifestyle-induced obesity, sarcopenic obesity, cardiovascular diseases and accompanying new disease symptoms can be seen in the advanced stages of treatment or in recovery periods. Complications such as nutritional deficiencies and anemia occur with long-term irregular nutrition. During this period, the role of parents in children's diet is also important. While parents put pressure on excessive nutrition in the early stages of their children's treatment, they find it difficult to control the situation after recovery. Therefore, the risk of developing chronic diseases appears to be higher in children with post-treatment survival compared to their peers. This condition shows that the relationship of the disease with nutrition is important and dieticians who are experts in the subject are needed.

Keywords: Leukemia; child; malnutrition; obesity
REFERENCES:
  1. Juliusson G, Lazarevic V, Hörstedt AS, Hagberg O, Höglund M; Swedish Acute Leukemia Registry Group. Acute myeloid leukemia in the real world: why population-based registries are needed. Blood. 2012;119(17):3890-9. [Crossref]  [PubMed]  [PMC] 
  2. Redner A. Leukemias. In: Lanzkowsky P, ed. Manual of Peadiatric Hematology and Oncology. 5th ed. New York: Elsevier; 2011. p.518-66. [Crossref] 
  3. Ataseven E, Kantar M, Anacak M, Kamer S, Ertan Y, Caner A, et al. Ege Üniversitesi Hastanesi çocukluk çağı tümörlerinde epidemiyoloji ve sağ kalım özellikleri. [Epidemiology and survival characteristics of childhood tumors in Ege University Hospital]. Ege Journal of Medicine. 2019;58(Ek sayı):105-13. [Crossref] 
  4. Lim JY, Bhatia S, Robison LL, Yang JJ. Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia. Cancer. 2014;120(7):955-62. [Crossref]  [PubMed]  [PMC] 
  5. Hunger SP, Mullighan CG. Acute Lymphoblastic Leukemia in Children. N Engl J Med. 2015;373(16):1541-52. [Crossref]  [PubMed] 
  6. Juliusson G, Hough R. Leukemia. Prog Tumor Res. 2016;43:87-100. [Crossref]  [PubMed] 
  7. Howard SC, Riberio RC, Pui CH. Acute complications. In: Pui CH, ed. Childhood Leukemias. 3rd ed. Cambridge: Cambridge University Press; 2012. p. 660-700. [Link] 
  8. O'Connor D, Bate J, Wade R, Clack R, Dhir S, Hough R, et al. Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003. Blood. 2014;124(7):1056-61. [Crossref]  [PubMed] 
  9. Yazbeck N, Samia L, Saab R, Abboud MR, Solh H, Muwakkit S. Effect of malnutrition at diagnosis on clinical outcomes of children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2016;38(2):107-10. [Crossref]  [PubMed] 
  10. Bauer J, Jürgens H, Frühwald MC. Important aspects of nutrition in children with cancer. Adv Nutr. 2011;2(2):67-77. [Crossref]  [PubMed]  [PMC] 
  11. Thomsen M, Vitetta L. Adjunctive treatments for the prevention of chemotherapy- and radiotherapy-ınduced mucositis. Integr Cancer Ther. 2018;17(4):1027-47. [Crossref]  [PubMed]  [PMC] 
  12. Büntzel J, Riesenbeck D, Glatzel M, Berndt-Skorka R, Riedel T, Mücke R, et al. Limited effects of selenium substitution in the prevention of radiation-associated toxicities. results of a randomized study in head and neck cancer patients. Anticancer Res. 2010;30(5):1829-32. [PubMed] 
  13. Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, et al; Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;120(10):1453-61. Erratum in: Cancer. 2015;121(8):1339. [Crossref]  [PubMed]  [PMC] 
  14. Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36(1):11-48. [Crossref]  [PubMed] 
  15. Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci. 2010;35(8):427-33. [Crossref]  [PubMed]  [PMC] 
  16. Antillon F, Rossi E, Molina AL, Sala A, Pencharz P, Valsecchi MG, et al. Nutritional status of children during treatment for acute lymphoblastic leukemia in Guatemala. Pediatr Blood Cancer. 2013;60(6):911-5. [Crossref]  [PubMed] 
  17. Pribnow AK, Ortiz R, Báez LF, Mendieta L, Luna-Fineman S. Effects of malnutrition on treatment-related morbidity and survival of children with cancer in Nicaragua. Pediatr Blood Cancer. 2017;64(11). [Crossref]  [PubMed] 
  18. Tan SY, Poh BK, Nadrah MH, Jannah NA, Rahman J, Ismail MN. Nutritional status and dietary intake of children with acute leukaemia during induction or consolidation chemotherapy. J Hum Nutr Diet. 2013;26 Suppl 1:23-33. [Crossref]  [PubMed] 
  19. Shams-White M, Kelly MJ, Gilhooly C, Liu S, Must A, Parsons SK, et al. Food craving and obesity in survivors of pediatric ALL and lymphoma. Appetite. 2016;96:1-6. [Crossref]  [PubMed]  [PMC] 
  20. Galitzky J, Bouloumié A. Human visceral-fat-specific glucocorticoid tuning of adipogenesis. Cell Metab. 2013;18(1):3-5. [Crossref]  [PubMed] 
  21. Cohen J, Wakefield CE, Tapsell LC, Walton K, Fleming CA, Cohn RJ. Exploring the views of parents regarding dietary habits of their young cancer-surviving children. Support Care Cancer. 2015;23(2):463-71. [Crossref]  [PubMed] 
  22. Winter C, Müller C, Hoffmann C, Boos J, Rosenbaum D. Physical activity and childhood cancer. Pediatr Blood Cancer. 2010;54(4):501-10. [PubMed] 
  23. Zhang FF, Kelly MJ, Saltzman E, Must A, Roberts SB, Parsons SK. Obesity in pediatric ALL survivors: a meta-analysis. Pediatrics. 2014 Mar;133(3):e704-15. [Crossref]  [PubMed]  [PMC] 
  24. Zhang FF, Liu S, Chung M, Kelly MJ. Growth patterns during and after treatment in patients with pediatric ALL: A meta-analysis. Pediatr Blood Cancer. 2015;62(8):1452-60. [Crossref]  [PubMed]  [PMC] 
  25. Withycombe JS, Smith LM, Meza JL, Merkle C, Faulkner MS, Ritter L, et al. Weight change during childhood acute lymphoblastic leukemia induction therapy predicts obesity: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2015;62(3):434-9. [Crossref]  [PubMed]  [PMC] 
  26. Marriott CJC, Beaumont LF, Farncombe TH, Cranston AN, Athale UH, Yakemchuk VN, et al. Body composition in long-term survivors of acute lymphoblastic leukemia diagnosed in childhood and adolescence: A focus on sarcopenic obesity. Cancer. 2018;124(6):1225-31. [Crossref]  [PubMed] 
  27. Inaba H, Surprise HC, Pounds S, Cao X, Howard SC, Ringwald-Smith K, et al. Effect of body mass index on the outcome of children with acute myeloid leukemia. Cancer. 2012;118(23):5989-96. [Crossref]  [PubMed]  [PMC] 
  28. Esbenshade AJ, Simmons JH, Koyama T, Koehler E, Whitlock JA, Friedman DL. Body mass index and blood pressure changes over the course of treatment of pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2011;56(3):372-8. [Crossref]  [PubMed]  [PMC] 
  29. Armenian SH, Gibson CJ, Rockne RC, Ness KK. Premature aging in young cancer survivors. J Natl Cancer Inst. 2019;111(3):226-32. [Crossref]  [PubMed] 
  30. Hudson MM, Ness KK, Gurney JG, Mulrooney DA, Chemaitilly W, Krull KR, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013;309(22):2371-81. Erratum in: JAMA. 2013;310(1):99. [Crossref]  [PubMed]  [PMC] 
  31. Landy DC, Lipsitz SR, Kurtz JM, Hinkle AS, Constine LS, Adams MJ, et al. Dietary quality, caloric intake, and adiposity of childhood cancer survivors and their siblings: An analysis from the cardiac risk factors in childhood cancer survivors study. Nutr Cancer. 2013;65(4):547-55. [Crossref]  [PubMed] 
  32. Smith WA, Li C, Nottage KA, Mulrooney DA, Armstrong GT, Lanctot JQ, et al. Lifestyle and metabolic syndrome in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study. Cancer. 2014;120(17): 2742-50. [Crossref]  [PubMed]  [PMC] 
  33. Tonorezos ES, Robien K, Eshelman-Kent D, Moskowitz CS, Church TS, Ross R, et al. Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia. Cancer Causes Control. 2013;24(2):313-21. [Crossref]  [PubMed]  [PMC] 
  34. Zhang FF, Ojha RP, Krull KR, Gibson TM, Lu L, Lanctot J, et al. Adult survivors of childhood cancer have poor adherence to dietary guidelines. J Nutr. 2016;146(12):2497-505. [Crossref]  [PubMed]  [PMC] 
  35. Wampler MA, Galantino ML, Huang S, Gilchrist LS, Marchese VG, Morris GS, et al. Physical activity among adult survivors of childhood lower-extremity sarcoma. J Cancer Surviv. 2012;6(1):45-53. [Crossref]  [PubMed]  [PMC] 
  36. Stern M, Lamana L, Russell C, Edwin L, Thompson A, Trapp S, et al. Adaptation of an obesity ıntervention program for pediatric cancer survivors (NOURISH-T). Clinical Practical in Pediatrik Psychology. 2013:1(3):264-75. [Crossref] 
  37. Fleming CA, Cohen J, Murphy A, Wakefield CE, Cohn RJ, Naumann FL. Parent feeding interactions and practices during childhood cancer treatment. A qualitative investigation. Appetite. 2015;89:219-25. [Crossref]  [PubMed] 
  38. Zhang FF, Kelly M, Du M, Welch JG, Santacruz N, Rhoades J, et al. Early lifestyle intervention for obesity prevention in pediatric survivors of acute lymphoblastic leukemia. Nutrients. 2019;11(11):2631. [Crossref]  [PubMed]  [PMC] 
  39. Aldhafiri F, Al-Nasser A, Al-Sugair A, Al-Mutairi H, Young D, Reilly JJ. Obesity and metabolic syndrome in adolescent survivors of standard risk childhood acute lymphoblastic leukemia in Saudi Arabia. Pediatr Blood Cancer. 2012;59(1):133-7. [Crossref]  [PubMed] 
  40. Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev. 2013;12(10):976-89. [Crossref]  [PubMed] 
  41. Sun J. Vitamin D and mucosal immune function. Curr Opin Gastroenterol. 2010;26(6):591-5. [Crossref]  [PubMed]  [PMC] 
  42. Ladas EJ, Orjuela M, Stevenson K, Cole PD, Lin M, Athale UH, et al. Dietary intake and childhood leukemia: The Diet and Acute Lymphoblastic Leukemia Treatment (DALLT) cohort study. Nutrition. 2016;32(10):1103-09.e1. [Crossref]  [PubMed]  [PMC] 
  43. Genc DB, Vural S, Yagar G. The incidence of and factors associated with vitamin d deficiency in newly diagnosed children with cancer. Nutr Cancer. 2016;68(5):756-61. [Crossref]  [PubMed] 
  44. Neville KA, Walker JL, Cohn RJ, Cowell CT, White CP. The prevalence of Vitamin D deficiency is higher in adult survivors of childhood cancer. Clin Endocrinol (Oxf). 2015;82(5):657-62. [Crossref]  [PubMed] 
  45. Muggeo P, Muggeo VMR, Giordano P, Delvecchio M, Altomare M, Novielli C, et al. Cardiovascular dysfunction and vitamin D status in childhood acute lymphoblastic leukemia survivors. World J Pediatr. 2019;15(5):465-70. [Crossref]  [PubMed] 
  46. Wallace G, Jodele S, Howell J, Myers KC, Teusink A, Zhao X, et al. Vitamin D deficiency and survival in children after hematopoietic stem cell transplant. Biol Blood Marrow Transplant. 2015;21(9):1627-31. [Crossref]  [PubMed]  [PMC] 
  47. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30. Erratum in: J Clin Endocrinol Metab. 2011;96(12):3908. [Crossref]  [PubMed] 
  48. Demirsoy U, Sarper N, Aylan Gelen S, Zengin E, Kum T, Demir H. The association of oral vitamin D and calcium supplementation with bone mineral density in pediatric acute lymphoblastic leukemia patients. J Pediatr Hematol Oncol. 2017;39(4):287-92. [Crossref]  [PubMed] 
  49. Lee JY, So TY, Thackray J. A review on vitamin d deficiency treatment in pediatric patients. J Pediatr Pharmacol Ther. 2013;18(4):277-91. [Crossref]  [PubMed]  [PMC] 
  50. Kühl S, Götz H, Brochhausen C, Jakse N, Filippi A, d'Hoedt B, et al. The influence of substitute materials on bone density after maxillary sinus augmentation: a microcomputed tomography study. Int J Oral Maxillofac Implants. 2012;27(6):1541-6. [PubMed] 
  51. Caballero-Velázquez T, Montero I, Sánchez-Guijo F, Parody R, Salda-a R, Valcarcel D, et al; GETH (Grupo Espa-ol de Trasplante Hematopoyético). Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical Trial. Clin Cancer Res. 2016;22(23):5673-81. [Crossref]  [PubMed] 
  52. Steele M, Narendran A. Mechanisms of defective erythropoiesis and anemia in pediatric acute lymphoblastic leukemia (ALL). Ann Hematol. 2012;91(10):1513-8. [Crossref]  [PubMed] 
  53. Pattnaik J, Kayal S, Dubashi B, Basu D, Vinod KV, Nandeesha H, et al. Profile of anemia in acute lymphoblastic leukemia patients on maintenance therapy and the effect of micronutrient supplementation. Support Care Cancer. 2020;28(2):731-8. d [Crossref]  [PubMed] 
  54. Tandon S, Moulik NR, Kumar A, Mahdi AA, Kumar A. Effect of Pre-treatment nutritional status, folate and vitamin B12 Levels on Induction chemotherapy in children with acute lymphoblastic leukemia. Indian Pediatr. 2015;52(5):385-9. [Crossref]  [PubMed] 
  55. Wien TN, Pike E, Wisløff T, Staff A, Smeland S, Klemp M. Cancer risk with folic acid supplements: a systematic review and meta-analysis. BMJ Open. 2012;2(1):e000653. [Crossref]  [PubMed]  [PMC] 
  56. Liu Y, Wang B, Liu X, Xie X, Gu W, Li H, et al. Clinical variations of serum levels of ferritin, folic acid and vitamin B12 in acute leukemia patients. J Med Coll PLA. 2011;26(5):264-70. [Crossref] 

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com